Urothelial carcinoma following augmentation cystoplasty: an aggressive variant with distinct clinicopathological characteristics and molecular genetic alterations

Histopathology - Tập 55 Số 2 - Trang 161-173 - 2009
Ming‐Tse Sung1, Shaobo Zhang, Antonio López-Beltrán, Rodolfo Montironi, Ming‐Sheng Wang, Darrell D. Davidson, Michael O. Koch, Mark P. Cain, Richard C. Rink, Liang Cheng
1Department of Pathology, Chang Gung Memorial Hospital-Kaohsiung Medical Centre, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Tóm tắt

Aims:  Patients who have undergone intestinal augmentation cystoplasty are at risk for developing latent vesicle malignancy. The aim was to evaluate the histological and immunohistochemical characteristics and molecular genetic alterations in these neoplasms.Methods and results:  Four patients developing urothelial neoplasms after augmentation cystoplasty were included in the current study. The mean age of the patients, including two men and two women, was 37 years. The latency from bladder augmentation to developing malignancy ranged from 17 to 21 years (mean 19 years). All patients died of cancer shortly after diagnosis (mean 5 months). In the morphological evaluation, all tumours were high‐grade (grade 3) invasive urothelial carcinoma comprising various architectural patterns with brisk mitoses and tumour necrosis. Three harboured glandular differentiation and the remaining one showed squamous differentiation. All cases revealed abnormal decreasing β‐catenin expression. Two tumours showed nuclear expression of CDX2. On UroVysion fluorescence in situ hybridization (FISH) analysis, all tumours displayed characteristic chromosomal abnormalities. Point mutations of both FGFR3 and p53 genes were identified in one case.Conclusions:  Urothelial carcinomas developed after augmentation cystoplasty are extremely aggressive and exhibit distinct morphological, immunohistochemical and genetic characteristics. UroVysion FISH analysis may offer a surveillance strategy in patients who undergo augmentation cystoplasty.

Từ khóa


Tài liệu tham khảo

Mikulicz J, 1899, Zur operation der Augeborene blasenspate, Zentralbl. Chir., 26, 641

10.1097/01.ju.0000134890.07434.8e

10.1016/j.juro.2006.03.126

10.1097/01.ju.0000140194.87974.56

Eble JN, 2004, Pathology and genetics of tumours of the urinary system and male genital organs

Mostofi FK, 1973, Histological typing of urinary bladder tumours. International classification of tumors

10.1016/j.humpath.2006.08.016

10.1097/PAS.0b013e3181379edf

10.1158/1078-0432.CCR-07-4147

Bilim V, 2000, Altered expression of beta‐catenin in renal cell cancer and transitional cell cancer with the absence of beta‐catenin gene mutations, Clin. Cancer Res., 6, 460

10.1002/path.2129

10.1002/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M

Bakkar AA, 2003, FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder, Cancer Res., 63, 8108

10.1097/PAS.0b013e318060cb9d

10.1016/S0022-5347(17)40055-3

10.1016/S0090-4295(99)80296-9

10.1159/000030479

10.1016/S0022-5347(17)38767-0

10.1016/j.humpath.2006.05.009

10.1016/j.urology.2005.06.134

10.1016/j.urology.2007.03.033

10.1053/gast.2002.31902

10.1002/path.1741

10.1097/01.pas.0000131552.67613.fd

10.1038/modpathol.3800670

10.1038/modpathol.3800407

10.1083/jcb.120.3.757

Shimazui T, 1996, Prognostic value of cadherin‐associated molecules (alpha‐, beta‐, and gamma‐catenins and p120cas) in bladder tumors, Cancer Res., 56, 4154

10.1016/S0022-5347(01)62438-8

Moll R, 1995, Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas, Am. J. Pathol., 147, 1383

10.1309/PYQC-17CB-063T-Q07J

10.1097/00000478-200301000-00001

10.5858/2001-125-0921-CACIPU

10.1016/S0021-9258(19)78170-8

10.1002/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2

10.1200/JCO.2003.05.073

10.1002/path.1202

Fujimoto K, 1992, Frequent association of p53 gene mutation in invasive bladder cancer, Cancer Res., 52, 1393

10.1158/0008-5472.CAN-03-2421

Takahashi T, 1998, Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract, Cancer Res., 58, 5835

10.1126/science.959840

10.1007/s002400050050

10.1016/S0022-5347(17)35014-0

10.1016/0165-4608(93)90015-E

10.1016/S0022-5347(05)67104-2

10.1016/S0022-5347(05)64270-X

Brankley SM, 2008, A study of the reproducibility of a fluorescence in situ hybridization bladder cancer detection assay, Anal. Quant. Cytol. Histol., 30, 145

10.1309/DFJUHY3WPC9GUU2W

10.1111/j.1464-410X.1971.tb10044.x

10.1111/j.1464-410X.1987.tb05490.x

10.1016/S0022-5347(17)36016-0

10.1016/S0022-5347(01)65181-4

10.1016/S0022-5347(05)65388-8

10.1177/106689690301100216

10.1016/j.juro.2007.05.100